Filing Details
- Accession Number:
- 0001209191-14-065281
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-29 17:47:01
- Reporting Period:
- 2014-10-27
- Filing Date:
- 2014-10-29
- Accepted Time:
- 2014-10-29 17:47:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1454189 | Auspex Pharmaceuticals Inc. | ASPX | Pharmaceutical Preparations (2834) | 954862842 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1405712 | Cmea Ventures Vii Lp | One Letterman Drive Building C, Suite Cm500 San Francisco CA 94129 | No | No | Yes | No | |
1405972 | Cmea Ventures Vii (Parallel) Lp | One Letterman Drive Building C, Suite Cm500 San Francisco CA 94129 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-10-27 | 3,413 | $27.11 | 3,736,748 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-10-27 | 87 | $27.11 | 95,866 | No | 4 | S | Indirect | By: CMEA Ventures VII (Parallel) LP |
Common Stock | Disposition | 2014-10-28 | 10,725 | $26.99 | 3,726,023 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-10-28 | 275 | $26.99 | 95,591 | No | 4 | S | Indirect | By: CMEA Ventures VII (Parallel) LP |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Indirect | By: CMEA Ventures VII (Parallel) LP |
No | 4 | S | Direct | |
No | 4 | S | Indirect | By: CMEA Ventures VII (Parallel) LP |
Footnotes
- The shares sold on this date were sold in multiple transactions. The price is the weighted average price per share, the actual sales price per share ranged from $26.645 to $27.43.
- The shares sold on this date were sold in multiple transactions. The price is the weighted average price per share, the actual sales price per share ranged from $26.595 to $27.40.